LKFT SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 26, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 27, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 28, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 23, 2023

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 24, 2022

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 25, 2021

News

TYPE

HEADLINE

FILED AT

6-K

Lakefront Biotherapeutics Announces Positive Gamgertamig Phase 1b Data in Autoimmune Cytopenias to be Presented at ASH 2026

Nov 4, 2026

6-K

Lakefront Biotherapeutics Appoints Dr. Mehdi Shahidi to its Board of Directors

Nov 2, 2026

6-K

Lakefront Biotherapeutics Completes Share Repurchase Program

Oct 20, 2026

6-K

Lakefront Sells Preclinical CAR-T Programs to Armed Cell Therapeutics

Oct 14, 2026

6-K

Lakefront Biotherapeutics NV Announces Share Repurchase Transactions

Oct 13, 2026

6-K

Lakefront Receives Transparency Notification from Bank of America

Oct 9, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

OFFERING - OTHER | Bank: CITIBANK, N.A.

May 8, 2026

424B3

Registration

Oct 12, 2018

424B5

2,575,107 American Depositary Shares

Sep 14, 2018

424B5

1,237,745

Sep 12, 2018

424B5

3,750,000 American Depositary Shares

Apr 18, 2017

424B5

$275,000,000

Apr 17, 2017

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Dec 10, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Nov 20, 2024

S-8

Registration

Dec 4, 2023

S-8

Registration

Dec 12, 2022

S-8

Registration

Oct 26, 2021

S-8

Registration

Oct 9, 2020

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

Madison Avenue Partners, LP (Filed by)

Jun 23, 2026

SCHEDULE 13G

TANG CAPITAL MANAGEMENT LLC (Filed by)

Oct 29, 2025

SCHEDULE 13D/A

EcoR1 Capital, LLC (Filed by)

Jul 28, 2025

SCHEDULE 13D/A

EcoR1 Capital, LLC (Filed by)

May 19, 2025

SCHEDULE 13D

TANG CAPITAL MANAGEMENT LLC (Filed by)

Feb 14, 2025

SCHEDULE 13D/A

GILEAD SCIENCES, INC. (Filed by)

Jan 10, 2025

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Oct 2, 2017

CORRESP

Form CORRESP - Correspondence

Sep 13, 2017

LETTER

Form UPLOAD - SEC-generated letter

Sep 5, 2017

CORRESP

Form CORRESP - Correspondence

Aug 16, 2017

LETTER

Form UPLOAD - SEC-generated letter

Aug 2, 2017

CT ORDER

Form CT ORDER - Confidential treatment order

Jul 27, 2016

Lakefront Biotherapeutics N.V. LKFT · SEC Filings